Case Report
BibTex RIS Cite

Status Epileptikus Tablosu İle Başvuran Hastada Tespit Edilen Takayasu Hastalığı

Year 2020, Volume: 3 Issue: 1, 28 - 31, 20.02.2020

Abstract

Nabızsızlık hastalığı olarak bilinen Takayasu
Arteriti (TA) hafif semptomlarla kendini ortaya koyabileceği gibi hastalığın
ilerlemesine bağlı olarak ağır komplikasyonlara da neden olabilir. TA öncelikli
olarak karotis, subklavyen, vertebral, renal ve aorta gibi büyük arterleri
tutar. Aynı zamanda koroner ve pulmoner arterleri de tutabilen kronik bir
vaskülittir. Başlangıçta ateş, halsizlik, gece terlemesi, kilo kaybı, miyalji,
baş dönmesi ve senkop gibi nonspesifik bulgularla seyrettiği için tanıda
gecikmeler olabilir. Bu yüzden özellikle genç kadınlarda vaskülit farkındalığı
önem arz etmektedir. Biz bu olguda durdurulamayan epileptik nöbet ile hastaneye
başvuran ve mekanik ventilasyon desteği için yoğun bakım ünitesinde takip
edilen hastamızda tespit ettiğimiz TA’yı sunmayı amaçladık.

Supporting Institution

Selçuk Üniversitesi Tıp Fakültesi

Thanks

Prof.Dr. Jale Bengi Çelik , Doç.Dr. İskender Kara

References

  • Numano F. Thestory of Takayasu arteritis. Rheumatology (Oxford). 2002;41:103–6. doi:10.1093/rheumatology/41.1.103
  • Oner FA, Direskeneli H. Update on Takayasu's arteritis. La Presse Medicale. 2015;44:259-65. doi:10.1016/j.lpm.2015.01.015
  • Keser G, Aksu K. Dirençli Takayasu arteriti tedavisi. Management of resistantTakayasu arteritis. RAED Dergisi. 2011;3(1-2):20-28. doi:10.2399/raed.11.004
  • Koike H, Ashizawa K, Hayashi H, et al. Takayasu Arteritis Presenting as Unexplained Pulmonary Consolidation: A Case Report. Vasc Endovascular Surg. 2018;52(7):579-82. doi:10.1177/1538574418775186
  • Gümüşçü F, Benli ED, Demirtaş S, Karahan O. A case with late clinical presentation of Takayasu’s arteritis. Dicle Tıp Derg. 2014;41(2):421-24. doi:10.5798/diclemedj.0921.2014.02.0445
  • Barra L, Yang G, Pagnoux C, The Canadian Vasculitis Network (CanVasc). Non-glucocorticoid drugs for the treatment of Takayasu's arteritis: A systematic review and meta-analysis. Autoimmunity Reviews. 2018;17(7):683–93. doi:10.1016/j.autrev.2018.01.019
  • Sun Y, Huang Q, Jiang L. Radiology and biomarkers in assessing disease activity in Takayasu arteritis. International Journal of Rheumatic Diseases. 2019;Jan;22 Suppl1:53-59. doi:10.1111/1756-185x.13286
  • Mason JC. Takayasu arteritis-advances in diagnosis and management. Nat Rev Rheumatol 2010;6(7):406-15. doi:10.1038/nrrheum.2010.82
  • Schmidt J, Kermani TA, Bacani AK, et al. Diagnosticfeatures, treatment, andoutcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clin Proc 2013;88(8):822–30.doi:10.1016/j.mayocp.2013.04.025

A Case of Takayasu Arteritis Diagnosed in a Patient Presenting with Status Epilepticus

Year 2020, Volume: 3 Issue: 1, 28 - 31, 20.02.2020

Abstract

Takayasu
Arteritis (TA), also known as pulsless disease, can manifest itself with mild
symptoms or cause severe complications depending on the progression of the
disease. TA primarily involves large arteries such as carotid, subclavian, vertebral,
renal and aorta. It is a chronic vasculitis that can also involve the coronary
and pulmonary arteries. There may be delays in diagnosis since it initially
presents with nonspecific findings such as fever, weakness, night sweats,
weight loss, myalgia, dizziness and syncope. Therefore, awareness of vasculitis
is important especially in young women. In this case, we aimed to present our
patient who was admitted to the hospital with a persistent epileptic seizure
and followed up in the intensive care unit for mechanical ventilation support.
Then he has been diagnosed with TA during his clinical management.

References

  • Numano F. Thestory of Takayasu arteritis. Rheumatology (Oxford). 2002;41:103–6. doi:10.1093/rheumatology/41.1.103
  • Oner FA, Direskeneli H. Update on Takayasu's arteritis. La Presse Medicale. 2015;44:259-65. doi:10.1016/j.lpm.2015.01.015
  • Keser G, Aksu K. Dirençli Takayasu arteriti tedavisi. Management of resistantTakayasu arteritis. RAED Dergisi. 2011;3(1-2):20-28. doi:10.2399/raed.11.004
  • Koike H, Ashizawa K, Hayashi H, et al. Takayasu Arteritis Presenting as Unexplained Pulmonary Consolidation: A Case Report. Vasc Endovascular Surg. 2018;52(7):579-82. doi:10.1177/1538574418775186
  • Gümüşçü F, Benli ED, Demirtaş S, Karahan O. A case with late clinical presentation of Takayasu’s arteritis. Dicle Tıp Derg. 2014;41(2):421-24. doi:10.5798/diclemedj.0921.2014.02.0445
  • Barra L, Yang G, Pagnoux C, The Canadian Vasculitis Network (CanVasc). Non-glucocorticoid drugs for the treatment of Takayasu's arteritis: A systematic review and meta-analysis. Autoimmunity Reviews. 2018;17(7):683–93. doi:10.1016/j.autrev.2018.01.019
  • Sun Y, Huang Q, Jiang L. Radiology and biomarkers in assessing disease activity in Takayasu arteritis. International Journal of Rheumatic Diseases. 2019;Jan;22 Suppl1:53-59. doi:10.1111/1756-185x.13286
  • Mason JC. Takayasu arteritis-advances in diagnosis and management. Nat Rev Rheumatol 2010;6(7):406-15. doi:10.1038/nrrheum.2010.82
  • Schmidt J, Kermani TA, Bacani AK, et al. Diagnosticfeatures, treatment, andoutcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clin Proc 2013;88(8):822–30.doi:10.1016/j.mayocp.2013.04.025
There are 9 citations in total.

Details

Primary Language Turkish
Subjects Rheumatology and Arthritis, Intensive Care
Journal Section Olgu Sunumu
Authors

Hatice Eyiol

İskender Kara

Publication Date February 20, 2020
Submission Date December 2, 2019
Acceptance Date February 6, 2020
Published in Issue Year 2020 Volume: 3 Issue: 1

Cite

AMA Eyiol H, Kara İ. Status Epileptikus Tablosu İle Başvuran Hastada Tespit Edilen Takayasu Hastalığı. Acta Med Nicomedia. February 2020;3(1):28-31.

images?q=tbn:ANd9GcSZGi2xIvqKAAwnJ5TSwN7g4cYXkrLAiHoAURHIjzbYqI5bffXt&s

The articles in the Journal of "Acta Medica Nicomedia" are open access articles licensed under a Creative Commons Attribution-ShareAlike 4.0 International License at the web address https://dergipark.org.tr/tr/pub/actamednicomedia